Skin Treatment - G20

  • G20
  • In 2024, the Skin Treatment market market in G20 countries is projected to generate a revenue of US$16.76bn.
  • It is anticipated that the market will experience an annual growth rate of 4.96% (CAGR 2024-2029).
  • When compared to other countries, the in the United States is the leading contributor to the global market, with a revenue of US$4,184.00m in 2024.
  • Taking into account the total population figures, the per person revenue in the Skin Treatment market market is estimated to be US$3.37 in 2024.
  • In the United States, the trend in the skin treatment OTC pharmaceutical market is a growing demand for natural and organic products.

Key regions: Australia, Brazil, Canada, China, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Skin Treatment market in G20 is experiencing significant growth and development due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors.

Customer preferences:
Customers in the Skin Treatment market in G20 are increasingly seeking products and services that cater to their specific skin concerns and needs. They are looking for effective solutions to address issues such as acne, aging, and hyperpigmentation. Additionally, there is a growing demand for natural and organic products as customers become more conscious of the ingredients they apply to their skin. Furthermore, customers are increasingly seeking personalized skincare routines and treatments that are tailored to their individual skin types and conditions.

Trends in the market:
One of the key trends in the Skin Treatment market in G20 is the rise of innovative skincare technologies and treatments. Advancements in technology have led to the development of new and improved skincare devices, such as laser and light therapy devices, which offer effective and non-invasive solutions for various skin concerns. Additionally, there is a growing trend towards multi-step skincare routines, influenced by the Korean skincare routine, which involves multiple products and steps to achieve optimal skin health. Moreover, there is an increasing popularity of medical aesthetic treatments, such as Botox and dermal fillers, as customers seek more advanced and long-lasting solutions for their skin concerns.

Local special circumstances:
The Skin Treatment market in G20 is influenced by various local special circumstances. For example, in countries with high levels of air pollution, customers may be more inclined to purchase skincare products that offer protection against environmental damage. Additionally, cultural preferences and beauty standards can also impact the market. In some countries, there may be a greater emphasis on achieving fair and even skin tone, leading to a higher demand for products that target hyperpigmentation. Furthermore, the availability and accessibility of skincare products and services can vary across countries, affecting customer preferences and market dynamics.

Underlying macroeconomic factors:
The growth and development of the Skin Treatment market in G20 are also influenced by underlying macroeconomic factors. Factors such as rising disposable incomes, urbanization, and changing lifestyles contribute to increased spending on skincare products and treatments. Moreover, the aging population in many G20 countries drives the demand for anti-aging skincare products and services. Additionally, the influence of social media and beauty influencers plays a significant role in shaping customer preferences and driving market growth.In conclusion, the Skin Treatment market in G20 is experiencing growth and development driven by customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. Customers are seeking personalized and effective solutions for their skin concerns, leading to the rise of innovative technologies and treatments. Local special circumstances and underlying macroeconomic factors further shape the market dynamics in each country within the G20.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)